These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16503826)

  • 1. Calcium-channel modulators for cardiovascular disease.
    Godfraind T
    Expert Opin Emerg Drugs; 2006 Mar; 11(1):49-73. PubMed ID: 16503826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antioxidant effects and the therapeutic mode of action of calcium channel blockers in hypertension and atherosclerosis.
    Godfraind T
    Philos Trans R Soc Lond B Biol Sci; 2005 Dec; 360(1464):2259-72. PubMed ID: 16321796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Actions of calcium channel blockers on vascular proteoglycan synthesis: relationship to atherosclerosis.
    Survase S; Ivey ME; Nigro J; Osman N; Little PJ
    Vasc Health Risk Manag; 2005; 1(3):199-208. PubMed ID: 17319105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Goals of antihypertensive therapy.
    McVeigh GE; Flack J; Grimm R
    Drugs; 1995 Feb; 49(2):161-75. PubMed ID: 7729325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of calcium antagonists in the treatment of arterial hypertension].
    Velasco M; Negrín C
    Invest Clin; 1997 Nov; 38 Suppl 2():65-72. PubMed ID: 9471233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular effects of calcium channel antagonists: new evidence.
    Richard S
    Drugs; 2005; 65 Suppl 2():1-10. PubMed ID: 16398057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium channel blockers in cardiovascular pharmacotherapy.
    Godfraind T
    J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):501-15. PubMed ID: 24872348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD008117. PubMed ID: 24488616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
    JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.
    Psaty BM; Lumley T; Furberg CD; Schellenbaum G; Pahor M; Alderman MH; Weiss NS
    JAMA; 2003 May; 289(19):2534-44. PubMed ID: 12759325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
    Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
    High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Calcium Channel Blockers Versus Other Classes of Antihypertensive Medication in the Treatment of Hypertensive Patients With Previous Stroke and/or Coronary Artery Disease: A Systematic Review and Meta-Analysis.
    Jeffers BW; Robbins J; Bhambri R
    Am J Ther; 2017; 24(1):e68-e80. PubMed ID: 26588586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigational calcium channel blockers for the treatment of hypertension.
    Tamargo J; Ruilope LM
    Expert Opin Investig Drugs; 2016 Nov; 25(11):1295-1309. PubMed ID: 27696904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacies of antihypertensive drugs.
    Aursnes I; Tvete IF; Gåsemyr J; Natvig B
    Scand Cardiovasc J; 2003 May; 37(2):72-9. PubMed ID: 12775305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current treatment of patients with hypertension: therapeutic implications of INSIGHT.
    Taddei S; Ghiadoni L; Salvetti A
    Drugs; 2003; 63(14):1435-44. PubMed ID: 12834362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs--overview and meta-analyses.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2015 Feb; 33(2):195-211. PubMed ID: 25485720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ca2+ channel subtypes and pharmacology in the kidney.
    Hayashi K; Wakino S; Sugano N; Ozawa Y; Homma K; Saruta T
    Circ Res; 2007 Feb; 100(3):342-53. PubMed ID: 17307972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
    Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of calcium channel blockers in cardiovascular risk reduction: issues in Latin America.
    Alcocer L; Bendersky M; Acosta J; Urina-Triana M
    Am J Cardiovasc Drugs; 2010; 10(3):143-54. PubMed ID: 20524716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.